Institutional shares held 292,610
500 calls
0 puts
Total value of holdings $0
$0 calls
$0 puts
Market Cap N/A
Institutional ownership 0.44%
# of Institutions 6


Latest Institutional Activity in DCPH

Top Purchases

Q1 2024
Morgan Stanley Shares Held: 1.54M ($0)
Q1 2024
Armistice Capital, LLC Shares Held: 5.9M ($0)
Q1 2024
State Street Corp Shares Held: 3.1M ($0)
Q1 2024
Tang Capital Management LLC Shares Held: 600K ($0)
Q1 2024
Redmile Group, LLC Shares Held: 5.3M ($0)

Top Sells

Q2 2024
Tucker Asset Management LLC Shares Held: 0 ($0)
Q1 2024
Deerfield Management Company, L.P. (Series C) Shares Held: 5.13M ($0)
Q1 2024
Braidwell LP Shares Held: 610K ($0)
Q1 2024
Polar Capital Holdings PLC Shares Held: 1.5M ($0)
Q1 2024
Goldman Sachs Group Inc Shares Held: 1.96M ($0)

About DCPH

Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing vimseltinib, an orally administered, potent, and highly selective switch-control kinase inhibitor of colony stimulating factor 1 receptor (CSF1R) for the treatment of tenosynovial giant cell tumor (TGCT); and DCC-3116 to treat RAS/RAF mutant cancers that is in the preclinical-stage. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts.


Insider Transactions at DCPH

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
1.46M Shares
From 7 Insiders
Grant, award, or other acquisition 502K shares
Exercise of in-the-money or at-the-money derivatives securities 962K shares
Sell / Disposition
1M Shares
From 17 Insiders
Sale (or disposition) back to the issuer 712K shares
Disposition due to a tender of shares in a change of control transaction 274K shares
Open market or private sale 18.3K shares

Track Institutional and Insider Activities on DCPH

Follow Deciphera Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DCPH shares.

Notify only if

Insider Trading

Get notified when an Deciphera Pharmaceuticals, Inc. insider buys or sells DCPH shares.

Notify only if

News

Receive news related to Deciphera Pharmaceuticals, Inc.

Track Activities on DCPH